FDA Inspection 920921 — Chongqing Taihao Pharmaceutical Co., Ltd.
The FDA completed an inspection of Chongqing Taihao Pharmaceutical Co., Ltd. on Mar 13, 2015 in Jiulong Po District. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 13, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jiulong Po District (China)